Abbott (ABT) buy thesis: diversified growth, EXAS-driven cancer diagnostics upside, attractive valuation & dividend yield, ...

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

MMED expands its European diabetes tech reach with Abbott sensor integration, boosting user flexibility and its connected care ecosystem.

Abbott Laboratories (NYSE:ABT) operates across healthcare sectors including devices, diagnostics, nutrition, and ...

Compatibility now available in five countries, with additional markets expected throughout 2026.SAN DIEGO--(BUSINESS ...

Abbott Laboratories ABT used its second-quarter earnings call to press a forward message rather than dwell on the quarter ...

Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street Abbott Laboratories (NYSE:ABT) reported second-quarter ...

MiniMed automated insulin delivery and smart MDI systems can now be paired with Instinct and Instinct Go, made by Abbott, the smallest, longest-wear sensors in the company's portfolioNORTHRIDGE ...

The GLP-1 weight-loss and diabetes drug market stabilizes as generics gain traction, with innovators maintaining steady sales ...

Novo Nordisk has launched Awiqli, the world's first once-weekly basal insulin, in India. The therapy is aimed at easing ...

In July 2026, Tandem Diabetes Care announced that its t:slim X2 insulin pump with Control-IQ+ technology is now compatible ...

Omnipod 5 Automated Insulin Delivery System now available in 20 countries worldwide New web-based data platform Omnipod Discover simplifies diabetes insights for users, caregivers, and healthcare ...